234 related articles for article (PubMed ID: 32890701)
1. Identification of a prognostic signature of epithelial ovarian cancer based on tumor immune microenvironment exploration.
Liu J; Meng H; Nie S; Sun Y; Jiang P; Li S; Yang J; Sun R; Cheng W
Genomics; 2020 Nov; 112(6):4827-4841. PubMed ID: 32890701
[TBL] [Abstract][Full Text] [Related]
2. A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer.
Peng Y; Wang H; Huang Q; Wu J; Zhang M
J Ovarian Res; 2022 Jan; 15(1):8. PubMed ID: 35031063
[TBL] [Abstract][Full Text] [Related]
3. A novel immune-related prognostic signature in epithelial ovarian carcinoma.
Su T; Zhang P; Zhao F; Zhang S
Aging (Albany NY); 2021 Apr; 13(7):10289-10311. PubMed ID: 33819196
[TBL] [Abstract][Full Text] [Related]
4. Multi-omics analysis of tumor mutational burden combined with prognostic assessment in epithelial ovarian cancer based on TCGA database.
Liu J; Xu W; Li S; Sun R; Cheng W
Int J Med Sci; 2020; 17(18):3200-3213. PubMed ID: 33173439
[No Abstract] [Full Text] [Related]
5. A new nomogram model for prognosis of hepatocellular carcinoma based on novel gene signature that regulates cross-talk between immune and tumor cells.
Wang Y; Yang Y; Zhao Z; Sun H; Luo D; Huttad L; Zhang B; Han B
BMC Cancer; 2022 Apr; 22(1):379. PubMed ID: 35397536
[TBL] [Abstract][Full Text] [Related]
6. An immune-related prognostic signature for thyroid carcinoma to predict survival and response to immune checkpoint inhibitors.
Wu P; Sun W; Zhang H
Cancer Immunol Immunother; 2022 Mar; 71(3):747-759. PubMed ID: 34398303
[TBL] [Abstract][Full Text] [Related]
7. Identification of immune-related gene signature predicting survival in the tumor microenvironment of lung adenocarcinoma.
Zhao M; Li M; Chen Z; Bian Y; Zheng Y; Hu Z; Liang J; Huang Y; Yin J; Zhan C; Feng M; Wang Q
Immunogenetics; 2020 Dec; 72(9-10):455-465. PubMed ID: 33188484
[TBL] [Abstract][Full Text] [Related]
8. Development of a macrophages-related 4-gene signature and nomogram for the overall survival prediction of hepatocellular carcinoma based on WGCNA and LASSO algorithm.
Yang Z; Zi Q; Xu K; Wang C; Chi Q
Int Immunopharmacol; 2021 Jan; 90():107238. PubMed ID: 33316739
[TBL] [Abstract][Full Text] [Related]
9. Development of a prognostic signature for esophageal cancer based on nine immune related genes.
Zhang Z; Chen C; Fang Y; Li S; Wang X; Sun L; Zhou G; Ye J
BMC Cancer; 2021 Feb; 21(1):113. PubMed ID: 33541291
[TBL] [Abstract][Full Text] [Related]
10. Development of an immune gene prognostic classifier for survival prediction and respond to immunocheckpoint inhibitor therapy/chemotherapy in endometrial cancer.
Liu J; Chen X; Jiang Y; Cheng W
Int Immunopharmacol; 2020 Sep; 86():106735. PubMed ID: 32619957
[TBL] [Abstract][Full Text] [Related]
11. A methylation-driven genes prognostic signature and the immune microenvironment in epithelial ovarian cancer.
Tan M; Wang S; Li F; Xu H; Gao J; Zhu L
Carcinogenesis; 2022 Aug; 43(7):635-646. PubMed ID: 35639961
[TBL] [Abstract][Full Text] [Related]
12. ATP2C2 Has Potential to Define Tumor Microenvironment in Breast Cancer.
Liu J; Wei Y; Wu Y; Li J; Sun J; Ren G; Li H
Front Immunol; 2021; 12():657950. PubMed ID: 33936088
[TBL] [Abstract][Full Text] [Related]
13. A robust signature associated with patient prognosis and tumor immune microenvironment based on immune-related genes in lung squamous cell carcinoma.
Zhou H; Zhang H; Shi M; Wang J; Huang Z; Shi J
Int Immunopharmacol; 2020 Nov; 88():106856. PubMed ID: 32777677
[TBL] [Abstract][Full Text] [Related]
14. Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma.
Peng Y; Liu C; Li M; Li W; Zhang M; Jiang X; Chang Y; Liu L; Wang F; Zhao Q
Cancer Cell Int; 2021 Feb; 21(1):98. PubMed ID: 33568167
[TBL] [Abstract][Full Text] [Related]
15. A prognostic signature based on immune-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma.
Liu J; Wu Z; Wang Y; Nie S; Sun R; Yang J; Cheng W
Int Immunopharmacol; 2020 Nov; 88():106884. PubMed ID: 32795900
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of an immune gene-set based prognostic signature for soft tissue sarcoma.
Shen R; Liu B; Li X; Yu T; Xu K; Ma J
BMC Cancer; 2021 Feb; 21(1):144. PubMed ID: 33557781
[TBL] [Abstract][Full Text] [Related]
17. Identification of a prognostic immune signature for cervical cancer to predict survival and response to immune checkpoint inhibitors.
Yang S; Wu Y; Deng Y; Zhou L; Yang P; Zheng Y; Zhang D; Zhai Z; Li N; Hao Q; Song D; Kang H; Dai Z
Oncoimmunology; 2019; 8(12):e1659094. PubMed ID: 31741756
[TBL] [Abstract][Full Text] [Related]
18. Immune-Stromal Score Signature: Novel Prognostic Tool of the Tumor Microenvironment in Lung Adenocarcinoma.
Qi X; Qi C; Qin B; Kang X; Hu Y; Han W
Front Oncol; 2020; 10():541330. PubMed ID: 33072571
[No Abstract] [Full Text] [Related]
19. Development of a prognostic signature based on immune-related genes and the correlation with immune microenvironment in breast cancer.
Dong M; Cui X; Wang G; Zhang Q; Li X
Aging (Albany NY); 2022 Jul; 14(13):5427-5448. PubMed ID: 35793235
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis of prognostic tumor microenvironment-related genes in osteosarcoma patients.
Hu C; Liu C; Tian S; Wang Y; Shen R; Rao H; Li J; Yang X; Chen B; Ye L
BMC Cancer; 2020 Aug; 20(1):814. PubMed ID: 32854645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
